Assessment of blood-brain barrier function using near infrared fluorescence imaging techniques
使用近红外荧光成像技术评估血脑屏障功能
基本信息
- 批准号:371699-2009
- 负责人:
- 金额:$ 1.82万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2013
- 资助国家:加拿大
- 起止时间:2013-01-01 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The brain capillary endothelial cells that form the blood-brain barrier have an important role in providing the proper environment for maintaining normal brain function. Under normal conditions, the blood-brain barrier restricts the movement of solutes, macromolecules and cells from the blood to the brain. While once considered to be a static cellular barrier, it is now understood that the permeability of the brain capillary endothelial cells forming the blood-brain barrier can be altered in response to physiological and pathophysiological factors as well as drug therapy. The ability to quantitatively monitor changes in blood-brain barrier function is crucial in understanding both disease progression as well as advancing treatment strategies for a number of neurological conditions. The objective of the current proposal is to use a series of near infrared fluorescent (NIRF) dyes to assess selected blood-brain barrier function at both the cellular and whole animal level. The advantage of the NIRF dye approach is the low background fluorescence and deep penetration of the fluorescence signal in the NIR wavelengths. The proposal will focus on several specific transport/permeability pathways, including transcellular solute and macromolecule transport into and out of the brain, as well as cell junction integrity and immune cell migration and traficking in the blood-brain barrier. The long term objective of this research is the development of a NIRF imaging platform that can be used to monitor important blood-brain barrier function and quantitatively assess the impact of physiological and pathophysiological events that lead to alterations in normal blood-brain barrier function and ultimately alterations in neurological activity.
形成血脑屏障的脑毛细血管内皮细胞在为维持正常脑功能提供适当环境方面具有重要作用。 在正常情况下,血脑屏障限制溶质、大分子和细胞从血液到大脑的运动。 虽然曾经被认为是静态的细胞屏障,但现在人们了解到,形成血脑屏障的脑毛细血管内皮细胞的渗透性可以根据生理和病理生理因素以及药物治疗而改变。 定量监测血脑屏障功能变化的能力对于了解疾病进展以及推进许多神经系统疾病的治疗策略至关重要。 目前的建议的目的是使用一系列的近红外荧光(NIRF)染料,以评估选定的血脑屏障功能,在细胞和整个动物的水平。 NIRF染料方法的优点是低背景荧光和NIR波长中荧光信号的深度穿透。 该提案将集中在几个特定的运输/渗透性途径,包括跨细胞溶质和大分子运输进出大脑,以及细胞连接的完整性和免疫细胞的迁移和traficking在血脑屏障。本研究的长期目标是开发一种NIRF成像平台,可用于监测重要的血脑屏障功能,并定量评估导致正常血脑屏障功能改变并最终改变神经活动的生理和病理生理事件的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Miller, Donald其他文献
Enterobacteria-secreted particles induce production of exosome-like S1P-containing particles by intestinal epithelium to drive Th17-mediated tumorigenesis.
- DOI:
10.1038/ncomms7956 - 发表时间:
2015-04-24 - 期刊:
- 影响因子:16.6
- 作者:
Deng, Zhongbin;Mu, Jingyao;Tseng, Michael;Wattenberg, Binks;Zhuang, Xiaoying;Egilmez, Nejat K.;Wang, Qilong;Zhang, Lifeng;Norris, James;Guo, Haixun;Yan, Jun;Haribabu, Bodduluri;Miller, Donald;Zhang, Huang-Ge - 通讯作者:
Zhang, Huang-Ge
Differential Gene Expression Profiles and Selected Cytokine Protein Analysis of Mediastinal Lymph Nodes of Horses with Chronic Recurrent Airway Obstruction (RAO) Support an Interleukin-17 Immune Response
- DOI:
10.1371/journal.pone.0142622 - 发表时间:
2015-11-12 - 期刊:
- 影响因子:3.7
- 作者:
Korn, Alexandra;Miller, Donald;Ainsworth, Dorothy Marie - 通讯作者:
Ainsworth, Dorothy Marie
Glial Cells Missing Homologue 1 Is Induced in Differentiating Equine Chorionic Girdle Trophoblast Cells
- DOI:
10.1095/biolreprod.108.070920 - 发表时间:
2009-02-01 - 期刊:
- 影响因子:3.6
- 作者:
de Mestre, Amanda M.;Miller, Donald;Antczak, Douglas F. - 通讯作者:
Antczak, Douglas F.
Phase 2 Randomized Controlled Trial of Radiation Therapy Plus Concurrent Interferon-Alpha and Retinoic Acid Versus Cisplatin for Stage III Cervical Carcinoma
- DOI:
10.1016/j.ijrobp.2015.09.040 - 发表时间:
2016-01-01 - 期刊:
- 影响因子:7
- 作者:
Basu, Partha;Jenson, Alfred Bennett;Miller, Donald - 通讯作者:
Miller, Donald
Coronary Artery Disease Risk of Familial Hypercholesterolemia Genetic Variants Independent of Clinically Observed Longitudinal Cholesterol Exposure.
- DOI:
10.1161/circgen.121.003501 - 发表时间:
2022-04 - 期刊:
- 影响因子:7.4
- 作者:
Clarke, Shoa L.;Tcheandjieu, Catherine;Hilliard, Austin T.;Lee, Min;Lynch, Julie;Chang, Kyong-Mi;Miller, Donald;Knowles, Joshua W.;O'Donnell, Christopher;Tsao, Phil;Rader, Daniel J.;Wilson, Peter W.;Sun, Yan, V;Gaziano, Michael;Assimes, Themistocles L. - 通讯作者:
Assimes, Themistocles L.
Miller, Donald的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Miller, Donald', 18)}}的其他基金
Cellular Mechanisms Regulating Blood-Brain Barrier Permeability
调节血脑屏障通透性的细胞机制
- 批准号:
RGPIN-2016-06025 - 财政年份:2021
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Cellular Mechanisms Regulating Blood-Brain Barrier Permeability
调节血脑屏障通透性的细胞机制
- 批准号:
RGPIN-2016-06025 - 财政年份:2020
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Development and clinical assessment of novel biomarker drugs targeting SSAT1 for detection and therapeutic monitoring of glioblastoma
用于胶质母细胞瘤检测和治疗监测的新型靶向 SSAT1 生物标志物药物的开发和临床评估
- 批准号:
538823-2019 - 财政年份:2020
- 资助金额:
$ 1.82万 - 项目类别:
Collaborative Health Research Projects
Development and clinical assessment of novel biomarker drugs targeting SSAT1 for detection and therapeutic monitoring of glioblastoma
用于胶质母细胞瘤检测和治疗监测的新型靶向 SSAT1 生物标志物药物的开发和临床评估
- 批准号:
538823-2019 - 财政年份:2019
- 资助金额:
$ 1.82万 - 项目类别:
Collaborative Health Research Projects
Cellular Mechanisms Regulating Blood-Brain Barrier Permeability
调节血脑屏障通透性的细胞机制
- 批准号:
RGPIN-2016-06025 - 财政年份:2019
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Cellular Mechanisms Regulating Blood-Brain Barrier Permeability
调节血脑屏障通透性的细胞机制
- 批准号:
RGPIN-2016-06025 - 财政年份:2018
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Nanoparticle Based Cell Selective Modulation of SSAT1 Expression
基于纳米颗粒的 SSAT1 表达细胞选择性调节
- 批准号:
519893-2017 - 财政年份:2017
- 资助金额:
$ 1.82万 - 项目类别:
Engage Grants Program
Cellular Mechanisms Regulating Blood-Brain Barrier Permeability
调节血脑屏障通透性的细胞机制
- 批准号:
RGPIN-2016-06025 - 财政年份:2017
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Cellular Mechanisms Regulating Blood-Brain Barrier Permeability
调节血脑屏障通透性的细胞机制
- 批准号:
RGPIN-2016-06025 - 财政年份:2016
- 资助金额:
$ 1.82万 - 项目类别:
Discovery Grants Program - Individual
Development of magnetic nanoparticles to breakthrough the blood-brain barrier
开发磁性纳米粒子以突破血脑屏障
- 批准号:
446420-2013 - 财政年份:2014
- 资助金额:
$ 1.82万 - 项目类别:
Collaborative Health Research Projects
相似国自然基金
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
- 批准号:82371144
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
- 批准号:82371317
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
- 批准号:82370820
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
KLK10调控胶质—血管耦合与对话促缺血性卒中后血脑屏障修复的机制
- 批准号:82371465
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
气体信号分子硫化氢对颈动脉窦压力反射感受器的调节作用及机制
- 批准号:81100181
- 批准年份:2011
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
精神分裂症特异微小RNA的筛选、鉴定及其靶向调控功能研究
- 批准号:81000583
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
人脐血间充质干细胞成骨潜能亚群的特异性分子标志
- 批准号:30800232
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Stroke Connectome MRI biomarkers for VCID risk assessment
用于 VCID 风险评估的中风连接组 MRI 生物标志物
- 批准号:
10887028 - 财政年份:2023
- 资助金额:
$ 1.82万 - 项目类别:
Assessment of retinal and sublingual microcirculation as surrogate biomarkers for cerebral microcirculatory dynamics
评估视网膜和舌下微循环作为脑微循环动力学替代生物标志物
- 批准号:
10790198 - 财政年份:2023
- 资助金额:
$ 1.82万 - 项目类别:
Development and Assessment of Diagnostic Accuracy of a Telemedicine-Based Delirium Assessment Tool (The Tele-CAM)
基于远程医疗的谵妄评估工具(Tele-CAM)的诊断准确性的开发和评估
- 批准号:
10575167 - 财政年份:2023
- 资助金额:
$ 1.82万 - 项目类别:
Assessment of ultrasound-facilitated neurotherapeutics in Alzheimer's disease
超声辅助神经疗法治疗阿尔茨海默病的评估
- 批准号:
10901036 - 财政年份:2023
- 资助金额:
$ 1.82万 - 项目类别:
Assessment of fetal brain health via circulating exRNA carriers for opioid use disorder in pregnancy
通过循环 exRNA 载体评估妊娠期阿片类药物使用障碍的胎儿大脑健康
- 批准号:
10722040 - 财政年份:2023
- 资助金额:
$ 1.82万 - 项目类别:
Translational assessment of an FAK inhibitor for acute cerebroprotection
FAK 抑制剂急性脑保护作用的转化评估
- 批准号:
10673417 - 财政年份:2023
- 资助金额:
$ 1.82万 - 项目类别:
In Vitro assessment of cucurbit[6]uril detectability limit and blood brain barrier permeability
葫芦[6]尿检出限和血脑屏障通透性的体外评估
- 批准号:
573352-2022 - 财政年份:2022
- 资助金额:
$ 1.82万 - 项目类别:
University Undergraduate Student Research Awards
Stroke Connectome MRI biomarkers for VCID risk assessment
用于 VCID 风险评估的中风连接组 MRI 生物标志物
- 批准号:
10444411 - 财政年份:2022
- 资助金额:
$ 1.82万 - 项目类别:
MRI-Based Regional Assessment of Cerebral Metabolism Via 3D Quantitative BOLD
通过 3D 定量 BOLD 进行基于 MRI 的脑代谢区域评估
- 批准号:
10578782 - 财政年份:2022
- 资助金额:
$ 1.82万 - 项目类别:
MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients
MCLENA-1:评估来那度胺在遗忘性 MCI 患者中的临床试验
- 批准号:
10630526 - 财政年份:2022
- 资助金额:
$ 1.82万 - 项目类别:














{{item.name}}会员




